Login / Signup

Factors associated with initiation and persistence of urate-lowering therapy.

Mats DehlinEmin Hoxha EkströmMax PetzoldUlf StrömbergGunilla TelgLennart T H Jacobsson
Published in: Arthritis research & therapy (2017)
Only a minority of patients received ULT and a majority of these did not persist with treatment over the next 2 years. However, the older patients with renal impairment and comorbidities, possibly suffering from a more severe gout disease, were more likely to receive and persist with treatment. There is thus still room for considerable improvement with regards to management of ULT in gout.
Keyphrases